| Q26774563 | Advances in nutritional therapy in inflammatory bowel diseases: Review |
| Q31146183 | Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis |
| Q90339285 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults |
| Q92227360 | Diet and inflammatory bowel disease: The Asian Working Group guidelines |
| Q37613371 | Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis |
| Q35580817 | Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules |
| Q37118418 | High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients |
| Q38647854 | Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease |
| Q38378837 | Indian Society of Gastroenterology consensus statements on Crohn's disease in India. |
| Q47442534 | Inflammatory Bowel Disease: Effects on Bone and Mechanisms |
| Q51661843 | Interleukin-13 Inhibits Expression of cyp27b1 in Peripheral CD14+ Cells That Is Correlated With Vertebral Bone Mineral Density of Patients With Ulcerative Colitis. |
| Q36309346 | Life-course approach to nutrition. |
| Q41263747 | Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease |
| Q26864691 | Managing osteoporosis in ulcerative colitis: something new? |
| Q38635666 | Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance. |
| Q52665445 | Opportunistic screening for bone disease using abdominal CT scans obtained for other reasons in newly diagnosed IBD patients. |
| Q36747140 | Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease. |
| Q91856399 | Perspective on skeletal health in inflammatory bowel disease |
| Q50730953 | Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission. |
| Q26776142 | Risk factors for osteoporosis in inflammatory bowel disease patients |
| Q89126948 | Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis |
| Q37136913 | Sex-Specific Issues in Inflammatory Bowel Disease |
| Q52937650 | Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC). |
| Q91789251 | The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD |
| Q48056630 | The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care |
| Q35589931 | The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis |
| Q33765409 | Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. |